Skinive’s accuracy report “Dynamics of the neural network accuracy in the context of modernization of the algorithms of skin pathology recognition” is officially published at Social Science Research Network.
Skinive neural network uses a machine-learning algorithm to calculate the risk rating of skin pathologies. For this study, we used Skinive’s 2020 and 2021 versions trained on 64,000 and 115,000 images respectively. Three validation datasets were used to assess the sensitivity of the algorithm: precancer + cancer, HPV skin pathology, acne, containing 285 images in each set. The specificity has been calculated on a separate validation set containing 6,000 benign neoplasm cases.
The purpose of this study was to estimate the accuracy of Skinive’s algorithm.
We have improved the algorithm to show a statistically significant decrease in the number of neural network errors in determining the risks of skin pathologies.
The results of sensitivity and specificity of the Skinive neural network indicate that the algorithm is highly accurate in detecting various neoplasms and skin diseases. The sensitivity of the Skinive neural network in detecting malignant neoplasms was 89.1% and 95.4% in 2020 and 2021 respectively. The specificity of Skinive’s neural network in determining benign neoplasms was 95.3% in 2020 and 97.9% in 2021. For all skin neoplasms: in 2020, the sensitivity was 95.3%, for specificity 93.5%; in 2021, it was 97.9% and 97.1% respectively.
Download Full Report (PDF): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3974784
Recommended articles preview:
2nd June 2010
[AI Generated] What is heat rash?
OpenAI NN input: Many different types of skin rashes exist. They can be concerning, uncomfortable, or downright painful. One of the most common types is heat rash, or miliaria. Heat rash is a skin condition that often affects children and adults in hot, humid weather conditions. You can develop heat rash when your pores become […]
11th June 2021
Skinive announces participation in the IMCAS Conference & Dermatology Innovation Forum 2021
We are pleased to announce that Skinive has received CE Mark clearance in the European Union. The CE marking confirms that Skinive solutions meet the requirements of the European Medical Devices Directive (MDD). This clearance opens up the market significantly for our solutions. The CE mark covers 27 countries in the European Union. More importantly it […]
20th February 2020
Sharing knowledge and experience with Amsterdam Medical Data Science.
Nowadays, Artificial Intelligence technology is for sure not lacking of attention in media and academic publications. But how much use is made of the potential of Data Science and innovation in European medical practice? On February 18th, 2019, Skinive specialists attended a medical conference linking top-class healthcare professionals and DataScience at the VUmc Cancer Centre […]
